Avidity Biosciences
RNAM
#1910
Rank
โ‚ฌ9.74 B
Marketcap
63,11ย โ‚ฌ
Share price
0.00%
Change (1 day)
59.89%
Change (1 year)

EPS for Avidity Biosciences (RNAM)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,62ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,50ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ48.11%
2024-2,50ย โ‚ฌ
2022-2,89ย โ‚ฌ-9.02%
2021-3,17ย โ‚ฌ68.93%
2020-1,88ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,14ย โ‚ฌ-131.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,37ย โ‚ฌ-192.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-0,49ย โ‚ฌ-86.36%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-2,02ย โ‚ฌ-44.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-0,94ย โ‚ฌ-73.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-43,60ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,57ย โ‚ฌ-143.30%๐Ÿ‡บ๐Ÿ‡ธ USA